About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Comparison of Language Intervention Programs | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT00033150

A Comparison of Language Intervention Programs

Brief Summary: Nearly 7% of elementary school children present with difficulties learning and using language. Unfortunately, language impairments are often long lasting and may have serious social, a...

Lead sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD)•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

National Institute on Deafness and Other Communication Disorders (NIDCD)

Age

6 - 9 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•age 6 to 9 years
•score between 75 and 125 on the Matrices subtest of the Kaufman Brief Intelligence Test
•Speaking Quotient of 79 or lower on the Test of Language Development: Primary: 3rd Edition

Exclusion Criteria

•Previous participation in 8 or more hours of language intervention or classroom activities using any of the Fast ForWord, Laureate, or Earobics speech-language or reading software and/or the Lindamood-Bell auditory discrimination training
•Failure of a hearing screening test
•An episode of otitis media in the previous 12 months
•Evidence of focal brain lesion, traumatic brain injury, cerebral palsy, or seizure disorder
•Abnormality of oral structure or function impeding normal language production

Related studies

Neurophysiological Mechanisms of Language Comprehension

NCT05283265 · Language Disorders

Repetitive Transcranial Magnetic Stimulation Combined With Language Training for Language Disorders in Children With Global Developmental Delay

NCT07369960 · Developmental Delay Disorder, Repetitive Transcranial Magnetic Stimulation (rTMS), and more

Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia

NCT05741853 · Primary Progressive Aphasia, Dementia, and more

Enhancing Language Function in Aphasia

NCT05443633 · Aphasia, Acquired, Language Disorders, and more

Active Not RecruitingPhase 2

Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium

NCT04060017 · Autism Spectrum Disorder, Language Disorders

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 24, 2006Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment216

Start dateJun 2002

Last updatedApr 24, 2006

Condition

Language Disorders

Locations shown

Lawrence Public Schools USD 497

Lawrence, Kansas

Pflugerville Independent School District

Pflugerville, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 24, 2006Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions